Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Rubin, MA, Varambally S, Beroukhim R, Tomlins SA, Rhodes DR, Paris PL, Hofer, MD, Storz-Schweizer M, Kuefer R, Fletcher JA, Hsi BL, Byrne JA, Pienta KJ, Collins C, Sellers WR, Chinnaiyan AM, Department of Pathology, Brigham and Women's Hospital, Boston, MA.: Cancer Res 2004;64:3814–22

Autor: Bosland, Maarten C.

Publikováno v: In Urologic Oncology: Seminars and Original Investigations 2004 22(5):436-437

Re: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer - Tomlins SA, Rhodes DR, Perrier S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chirmaiyan AM

Publikováno v: European Urology. 51(5):1443-1444

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dris___00893::c596e25d779b4e9b7c2783437477373a

Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder

Autor: Xylinas, E., Robinson, B.D., Kluth, L.A., Volkmer, B.G., Hautmann, R., Küfer, R., Zerbib, M., Kwon, E., Thompson, R.H., Boorjian, S.A., Shariat, S.F.

Publikováno v: In European Journal of Surgical Oncology January 2014 40(1):121-127

Up-regulation of POM121 is linked to prostate cancer aggressiveness and serves as a prognostic biomarker.

Autor: Becker F; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany, Luebeck, Germany., Offermann A; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany, Luebeck, Germany; Research Center Borstel, Leibniz Lung Center, Borstel, Germany, Borstel Germany., Roesch MC; Department of Urology, University Hospital Schleswig-Holstein, Luebeck, Germany, Luebeck, Germany., Joerg V; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany, Luebeck, Germany., Roth D; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany, Luebeck, Germany., Lubczyk V; Department of Pathology, Klinik am Eichert Alb Fils Kliniken, Goeppingen, Germany, Goeppingen, Germany., Kuefer R; Department of Urology, Klinik am Eichert Alb Fils Kliniken, Goeppingen, Germany, Goeppingen, Germany., Sailer V; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany, Luebeck, Germany., Kirfel J; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany, Luebeck, Germany., Merseburger AS; Department of Urology, University Hospital Schleswig-Holstein, Luebeck, Germany, Luebeck, Germany., Perner S; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany, Luebeck, Germany; Research Center Borstel, Leibniz Lung Center, Borstel, Germany, Borstel Germany. Electronic address: sven.perner@uksh.de.

Publikováno v: Urologic oncology [Urol Oncol] 2022 Aug; Vol. 40 (8), pp. 380.e11-380.e18. Date of Electronic Publication: 2022 Jun 17.

The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.

Autor: Bastide, C.¹ bastide.c@libertysurf.fr, Kuefer, R.¹, Loeffler, M.¹, de Petriconi, R.¹, Gschwend, J.¹, Hautmann, R.¹

Publikováno v: Prostate Cancer & Prostatic Diseases. 2006, Vol. 9 Issue 3, p239-244. 6p. 5 Charts, 2 Graphs.